Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Excelsior Medical CoTPE:4104 -1.13%87 FCF Yield % is 1.69 as of Aug. 03, 2026, which is 69% below its 10-year median of 5.44. GuruFocus rates TPE:4104 with a GF Score™ of 87/100 and a GF Value™ of NT$87.68 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 118 Medical Distribution companies, Excelsior Medical Co ranks worse than 50.85% on this metric.
FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Excelsior Medical Co FCF Yield % Related Terms
Excelsior Medical Co FCF Yield % Historical Data
* Premium members only.
The historical data trend for Excelsior Medical Co's FCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, Excelsior Medical Co's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Excelsior Medical Co FCF Yield % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Excelsior Medical Co's FCF Yield % distribution charts can be found below:
* The bar in red indicates where Excelsior Medical Co's FCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Excelsior Medical Co (TPE:4104) has a FCF Yield % of 1.69 as of Aug. 03, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Excelsior Medical Co and its competitors. This is 69% below median its historical median of 5.44. According to the industry distribution chart, Excelsior Medical Co ranks #60 out of 118 companies in the Medical Distribution industry, placing it in the top 50.8%.
Is Excelsior Medical Co's FCF Yield % too high?
Excelsior Medical Co's current FCF Yield % of 1.69 is 69% below median its 10-year median of 5.44. The Medical Distribution industry median FCF Yield % is 1.82. Excelsior Medical Co's value of 1.69 is 7.1% below this industry median. Based on the distribution chart, Excelsior Medical Co ranks #60 out of 118 companies in the Medical Distribution industry, which is below the industry midpoint. Overall, Excelsior Medical Co has a GF Score™ of 87/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Excelsior Medical Co's FCF Yield % compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Excelsior Medical Co ranks #60 out of 118 companies for FCF Yield %. This places Excelsior Medical Co in the lower half of its industry. The industry median FCF Yield % is 1.82. Excelsior Medical Co's value of 1.69 is 7.1% below this benchmark. While the company's 10-year median is 5.44 vs. the industry median of 1.82, Excelsior Medical Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Medical Distribution company?
The median FCF Yield % among Medical Distribution companies is 1.82, based on 118 companies in the industry. Companies in the top quartile (top 25%) have a FCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Excelsior Medical Co's current FCF Yield % of 1.69 is 7.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Excelsior Medical Co and its competitors. For the Medical Distribution industry, the median FCF Yield % is 1.82 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Excelsior Medical Co's current FCF Yield % is 1.69, which is 69% below median its own 10-year median of 5.44. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Excelsior Medical Co stock overvalued right now?
Based on GuruFocus' analysis, Excelsior Medical Co (TPE:4104) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$87.68, compared to a current price of NT$70.00 — trading 20.2% below its estimated fair value. The current FCF Yield % is 1.69, which is 69% below median its 10-year median of 5.44 and 7.1% below the Medical Distribution industry median of 1.82. Excelsior Medical Co's overall GF Score™ is 87/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For Excelsior Medical Co (TPE:4104), the current FCF Yield % is 1.69 as of Aug. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Excelsior Medical Co (TPE:4104) Overvalued in 2026?
Based on GuruFocus' analysis, Excelsior Medical Co stock appears to be undervalued.
The current stock price of NT$70.00 is trading 20.2% below its estimated GF Value™ of NT$87.68.
GuruFocus considers Excelsior Medical Co to be Modestly Undervalued.
Key valuation signals for TPE:4104:
FCF Yield %: 1.69 (69% below median its 10-year median of 5.44)
GF Value™: NT$87.68 vs. price of NT$70.00 (20.2% below fair value)
Industry Position: 7.1% below the Medical Distribution median (#60 of 118)
No single metric tells the full story. See the TPE:4104 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Excelsior Medical Co Ltd is engaged in the sale of medical supplies and medicines, home medical devices, and medical equipment with brand names of local and foreign manufacturers. Its product offerings include Fasflo hollow fiber dialyzer, Renabio sodium chloride injection, acid concentrates, Sunder blood purification tubing set, JMS blood bags, etc. The Group's reportable segments include Excelsior, Dynamic, Arich, and Others. Maximum revenue is generated from the Excelsior segment. Geographically, it derives key revenue from Taiwan and also has a presence in Hong Kong, China, the Philippines, Malaysia, and Indonesia.
87GF Score
Get the complete analysis for TPE:4104
FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TPE:4104 has been successfully added to your 
